Company profile
OncoImmune company profile
OncoImmune is a clinical-stage biopharmaceutical company that engages in the discovery and development of biopharmaceuticals for the treatment of cancer and autoimmune disease. It has completed a Phase II clinical trial of CD24Fc for the prophylactic treatment of acute Graft versus Host Disease for leukemia patients undergoing hematopoietic stem cell transplantation and is poised to launch a pivotal trial for the indication. Oncolmmune was founded in 2000 and is based in Rockville, Maryland.
Business identity
- Website
- https://www.merck.com
- Contact email
- [email protected]
- Phone number
- (301)557-9119
- Operating status
- Closed
- Company type
- For Profit
- Employee range
- 10,001+ employees
- Revenue range
- $10M+
- Founded
- 2000-01-01, Year
Headquarters
- Headquarters
- Barbourmeade, Kentucky, United States
- Postal code
- 20852
- Country code
- US
- Continent
- North America